Editas Medicine Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	47.01	40.52	32.31	78.12	19.71	25.54
Revenue Growth	20.83%	25.39%	-58.64%	296.32%	-22.83%	-71.85%
Cost of Revenue	84.96	89.95	199.25	177.65	174.96	142.51
Gross Profit	-37.95	-49.43	-166.93	-99.53	-155.25	-116.96
Selling, General & Admin	45.51	49.9	71.99	69.65	70.7	76.18
Operating Expenses	45.51	49.9	71.99	69.65	70.7	76.18
Operating Income	-83.46	-99.34	-238.92	-169.18	-225.95	-193.15
Interest Expense	-4.07	-6.17	-2.19	-	-	-
Interest & Investment Income	6.08	8.31	16.25	17.57	5.52	0.61
Other Non Operating Income (Expenses)	2.79	-	-	-	-	0.04
EBT Excluding Unusual Items	-78.66	-97.2	-224.86	-151.62	-220.43	-192.5
Merger & Restructuring Charges	7.63	-56.92	-12.23	-	-	-
Gain (Loss) on Sale of Investments	-2.89	-2.19	-0	-1.6	-	-
Gain (Loss) on Sale of Assets	-0.03	-3.76	-	-	-	-
Pretax Income	-73.95	-160.06	-237.09	-153.22	-220.43	-192.5
Net Income	-73.95	-160.06	-237.09	-153.22	-220.43	-192.5
Net Income to Common	-73.95	-160.06	-237.09	-153.22	-220.43	-192.5
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	101	89	82	76	69	68
Shares Outstanding (Diluted)	101	89	82	76	69	68
Shares Change	21.72%	7.78%	8.39%	10.63%	1.55%	15.37%
EPS (Basic)	-0.73	-1.80	-2.88	-2.02	-3.21	-2.85
EPS (Diluted)	-0.73	-1.80	-2.88	-2.02	-3.21	-2.85
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-120.55	-165.85	-219.11	-136.9	-181.47	-171.78
Free Cash Flow Per Share	-1.19	-1.87	-2.66	-1.80	-2.64	-2.54
Gross Margin	-80.75%	-122.00%	-	-127.40%	-	-
Operating Margin	-177.56%	-245.15%	-739.37%	-216.56%	-1146.26%	-756.13%
Profit Margin	-157.32%	-395.01%	-733.72%	-196.13%	-1118.26%	-753.61%
Free Cash Flow Margin	-256.46%	-409.30%	-678.06%	-175.23%	-920.59%	-672.49%
EBITDA	-81.04	-94.06	-233.11	-163.12	-219.61	-188.09
EBITDA Margin	-172.40%	-232.13%	-	-208.80%	-	-
D&A For EBITDA	2.43	5.28	5.81	6.06	6.34	5.05
EBIT	-83.46	-99.34	-238.92	-169.18	-225.95	-193.15
EBIT Margin	-177.56%	-245.15%	-	-216.56%	-	-

SEC Filings: 10-K · 10-Q